Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELZUTIFAN vs BENDROFLUMETHIAZIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELZUTIFAN vs BENDROFLUMETHIAZIDE: Safety Overview

Metric BELZUTIFAN BENDROFLUMETHIAZIDE
Total FAERS Reports 1,021 1,009
Deaths Reported 82 4
Death Rate 8.0% 0.4%
Hospitalizations 550 780
Average Patient Age 60.2 yrs 72.8 yrs
% Female Patients 41.6% 64.4%
FDA Approval Date Aug 13, 2021 Approved Prior to Jan 1, 1982
Manufacturer Merck Sharp & Dohme LLC N/A
Route ORAL N/A
Marketing Status Prescription Discontinued